Last reviewed · How we verify
Palbociclib cost & pricing
Country-by-country comparison
Important caveats
- List vs net: what's shown is the manufacturer's list price (WAC in the US, public list price elsewhere). Actual payer + patient costs are after rebates, copay assistance, and insurance contributions, which can be 30–60% lower.
- Indication-dependent: some drugs have different prices for different indications or strengths. Where multiple are tracked, the most-common adult dose is shown.
- USD conversion: annual_cost_usd is converted at our most recent FX rate. Local currency is the authoritative figure.
- Coverage: reimbursement_status reflects whether a public payer reimburses the drug, not whether any commercial plan does.
Subscribe to pricing updates
Get every Palbociclib regulatory + pricing change in your RSS reader:
Related
- Palbociclib full drug profile
- Palbociclib CI brief
- palbociclib biosimilar tracker
- Cost-per-QALY calculator
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing